V Gallant

582 total citations
22 papers, 406 citations indexed

About

V Gallant is a scholar working on Infectious Diseases, Surgery and Epidemiology. According to data from OpenAlex, V Gallant has authored 22 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 9 papers in Surgery and 9 papers in Epidemiology. Recurrent topics in V Gallant's work include Tuberculosis Research and Epidemiology (13 papers), Diagnosis and treatment of tuberculosis (6 papers) and Infectious Diseases and Tuberculosis (5 papers). V Gallant is often cited by papers focused on Tuberculosis Research and Epidemiology (13 papers), Diagnosis and treatment of tuberculosis (6 papers) and Infectious Diseases and Tuberculosis (5 papers). V Gallant collaborates with scholars based in Canada and Morocco. V Gallant's co-authors include Libni Eapen, Shawn Malone, Julie Vachon, E Choan, Rajiv Samant, Roanne Segal, M McGuire, Simone Dahrouge, Derek J. Jonker and Neil Reaume and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

V Gallant

20 papers receiving 397 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
V Gallant	124	123	122	82	62	22	406
Oluwatoyin F. Bamgbola	55 0.4×	68 0.6×	102 0.8×	62 0.8×	30 0.5×	24	567
A. Doussau	57 0.5×	83 0.7×	39 0.3×	46 0.6×	44 0.7×	30	619
Gareth Roberts	117 0.9×	88 0.7×	31 0.3×	91 1.1×	26 0.4×	34	716
Tesfaye Madebo	97 0.8×	171 1.4×	162 1.3×	93 1.1×	17 0.3×	31	428
T Bush	55 0.4×	55 0.4×	38 0.3×	37 0.5×	93 1.5×	11	686
Stephen Marcella	100 0.8×	169 1.4×	142 1.2×	122 1.5×	61 1.0×	31	604
Jeremy Louissaint	116 0.9×	211 1.7×	28 0.2×	41 0.5×	37 0.6×	40	465
S Greenfield	123 1.0×	134 1.1×	24 0.2×	17 0.2×	34 0.5×	20	455
J Donck	212 1.7×	109 0.9×	68 0.6×	107 1.3×	5 0.1×	23	650

Countries citing papers authored by V Gallant

Since Specialization

Citations

This map shows the geographic impact of V Gallant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V Gallant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V Gallant more than expected).

Fields of papers citing papers by V Gallant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V Gallant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V Gallant. The network helps show where V Gallant may publish in the future.

Co-authorship network of co-authors of V Gallant

This figure shows the co-authorship network connecting the top 25 collaborators of V Gallant. A scholar is included among the top collaborators of V Gallant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V Gallant. V Gallant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vachon, Julie, et al.. (2018). Can we eliminate tuberculosis?: Tuberculosis in Canada, 2016. Canada Communicable Disease Report. 44. 75.

Vachon, Julie, et al.. (2018). Tuberculosis in Canada, 2016. Canada Communicable Disease Report. 44(3/4). 75–81. 53 indexed citations

Tuite, Ashleigh R., et al.. (2017). Stochastic agent-based modeling of tuberculosis in Canadian Indigenous communities. BMC Public Health. 17(1). 73–73. 20 indexed citations

Gallant, V, et al.. (2017). Tuberculosis drug resistance in Canada: 2006—2016. Canada Communicable Disease Report. 43(11). 236–241. 10 indexed citations

Gallant, V, Venkata R. Duvvuri, & M McGuire. (2017). Tuberculosis in Canada - Summary 2015. Canada Communicable Disease Report. 43(3/4). 77–82. 28 indexed citations

Gallant, V, et al.. (2017). La résistance aux antituberculeux au Canada : 2006 à 2016. Relevé des maladies transmissibles au Canada. 43(11). 269–275. 1 indexed citations

Gao, Zhiwei, et al.. (2015). A population-based study of tuberculosis case fatality in Canada: do Aboriginal peoples fare less well?. The International Journal of Tuberculosis and Lung Disease. 19(7). 772–779. 4 indexed citations

Gallant, V, et al.. (2015). A summary of tuberculosis in Canada, 2013. Canada Communicable Disease Report. 41(S2). 2–7. 3 indexed citations

McGuire, M, et al.. (2015). A summary of tuberculosis drug resistance in Canada, 2003−2013. Canada Communicable Disease Report. 41(S2). 8–15. 1 indexed citations

10.

Gallant, V, et al.. (2014). La tuberculose au Canada : 1924-2012. Relevé des maladies transmissibles au Canada. 40(6). 107–117.

11.

Gallant, V, et al.. (2014). Tuberculosis in Canada: 1924-2012. Canada Communicable Disease Report. 40(6). 99–108. 7 indexed citations

12.

Minion, Jessica, V Gallant, Joyce Wolfe, Frances Jamieson, & Richard Long. (2013). Multidrug and Extensively Drug-resistant Tuberculosis in Canada 1997–2008: Demographic and Disease Characteristics. PLoS ONE. 8(1). e53466–e53466. 33 indexed citations

13.

Nicholas, Garth, et al.. (2008). Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer. Journal of Thoracic Oncology. 3(2). 163–169. 17 indexed citations

14.

Malone, Shawn, Gad Perry, Libni Eapen, et al.. (2007). Mature Results of the Ottawa Phase II Study of Intermittent Androgen-Suppression Therapy in Prostate Cancer: Clinical Predictors of Outcome. International Journal of Radiation Oncology*Biology*Physics. 68(3). 699–706. 14 indexed citations

15.

Pantarotto, Jason, Shawn Malone, Simone Dahrouge, V Gallant, & Libni Eapen. (2006). Smoking is associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy. British Journal of Urology. 99(3). 564–569. 50 indexed citations

16.

Choan, E, et al.. (2006). Effective palliative radiotherapy for symptomatic recurrent or residual ovarian cancer. Gynecologic Oncology. 102(2). 204–209. 25 indexed citations

17.

Samant, Rajiv, et al.. (2006). Treatment of stage I seminoma: A 15-year review. Urologic Oncology Seminars and Original Investigations. 24(3). 180–183. 24 indexed citations

18.

Samant, Rajiv, et al.. (2006). The Preferred Treatment for Stage I Seminoma: A Survey of Canadian Radiation Oncologists. Clinical Oncology. 18(9). 696–699. 9 indexed citations

19.

Choan, E, Roanne Segal, Derek J. Jonker, et al.. (2005). A prospective clinical trial of green tea for hormone refractory prostate cancer: An evaluation of the complementary/alternative therapy approach. Urologic Oncology Seminars and Original Investigations. 23(2). 108–113. 94 indexed citations

20.

Gallant, V, et al.. (2004). Trastuzumab (T) and docetaxel (D) for the treatment of HER2 metastatic breast cancer (MBC): A literature based (LB) and individual patient data (IPD) meta-analysis (MA) of phase II trial. Journal of Clinical Oncology. 22(14_suppl). 706–706. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact